Key facts
| Price (PPV) | 60.70 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | irbesartanhydrochlorothiazide |
| Class | Agents acting on the renin-angiotensin system |
| ATC code | C09DA04 |
| Manufacturer | ZENITH PHARMA |
| Presentation | Boite de 10 |
| Nature | Médicament |
| Hospital price | 37.90 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement de l’hypertension artérielle essentielle. Cette association à dose fixe est indiquée chez les patients adultes dont la pression artérielle est insuffisamment contrôlée par l’irbésartan seul ou l’hydrochlorothiazide seul.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
11 other products contain the same active substance as Co-Arapro 300 mg / 12.5 mg (Irbesartan | Hydrochlorothiazide), at the same strength and in the same dosage form. The prices below are per pack: compare pack sizes before comparing prices.
Same pack size
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Irphi Plus 300 mg / 12.5 mg | PHI | Boite de 10 | 60.70 MAD | 6.07 / unit | — |
Other pack sizes
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Co-Icard 300 mg / 12.5 mg | COOPER PHARMA | Boite de 14 | 85 MAD | 6.07 / unit |
| Co-Irvel 300 mg / 12.5 mg | AFRIC-PHAR | Boite de 14 | 85 MAD | 6.07 / unit |
| Irphi Plus 300 mg / 12.5 mg | PHI | Boite de 20 | 88.50 MAD | 4.43 / unit |
| Co-Irbesar Sun 300 mg / 12.5 mg | SUN PHARMACEUTICALS NORTH AFRICA S.A | Boite de 28 | 158 MAD | 5.64 / unit |
| Co-Irvel 300 mg / 12.5 mg | AFRIC-PHAR | Boite de 28 | 158 MAD | 5.64 / unit |
| Co-Vepran 300 mg / 12.5 mg | SOTHEMA | Boite de 28 | 158 MAD | 5.64 / unit |
| Coavacor 300 mg / 12.5 mg | POLYMEDIC | Boite de 30 | 158.20 MAD | 5.27 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Co-Arapro 300 mg / 12.5 mg
Co-Arapro 300 mg / 12.5 mg belongs to the agents acting on the renin-angiotensin system therapeutic class. In Morocco, this drug is marketed by ZENITH PHARMA and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Co-Arapro 300 mg / 12.5 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Co-Arapro 300 mg / 12.5 mg
Answers to common questions from Moroccan patients about this drug.